Pharmaceutical & Drug Policy
Synthetic drug threats require a new international treaty
Pharmaceutical & Drug Policy
When medicine supply chains become weapons: China’s leverage and how the U.S. should respond
Pharmaceutical & Drug Policy
Marta Wosińska’s testimony before the House Select Committee on the Chinese Communist Party
Pharmaceutical & Drug Policy
Fair drug pricing requires legislation, not executive orders
Experts
Ryan Conrad
Visiting Fellow
- Economic Studies, Center on Health Policy
Vanda Felbab-Brown
Director
- Initiative on Nonstate Armed Actors,
Co-Director
- Africa Security Initiative,
Senior Fellow
- Foreign Policy, Strobe Talbott Center for Security, Strategy, and Technology